Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 1/20 | 0.60 |
| ▸ | PTGER4 | P35408 | 5/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | SRC | P12931 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5797985 | 0.84 | PTGER4 (0.58) | PTGER4KDM4EHTTPOLBPKM | |
| SCHEMBL17938383 | 0.83 | PTGER4 (0.56) | PTGER4KDM4EHTTPOLBPKM | |
| SCHEMBL29558375 | 0.82 | DHFR (0.79) | DHFRMAPTLMNAMEN1KMT2A | |
| SCHEMBL15380515 | 0.82 | DHFR (0.79) | DHFRMAPTLMNAMEN1KMT2A | |
| SCHEMBL15380522 | 0.82 | DHFR (0.79) | DHFRMAPTLMNAMEN1KMT2A | |
| SCHEMBL30145441 | 0.82 | DHFR (0.79) | DHFRMAPTLMNAMEN1KMT2A | |
| SCHEMBL409180 | 0.82 | DHFR (0.79) | DHFRMAPTLMNAMEN1KMT2A | |
| SCHEMBL29558033 | 0.82 | DHFR (0.79) | DHFRMAPTLMNAMEN1KMT2A | |
| SCHEMBL4779304 | 0.81 | PTGER4 (0.54) | PTGER4MAPTLMNAKDM4EHTT | |
| SCHEMBL4839011 | 0.81 | DHFR (0.64) | DHFRPTGER4MAPTLMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7364825-B2 | Charge transport materials having a nitrogen-containing-heterocycle hydrazone group | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-04-29 | — | — | US | disclosed |
| US-7291433-B2 | Poly(hydrazone)-based charge transport materials | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2007-11-06 | — | — | US | disclosed |
| EP-1584987-B1 | Poly(hydrazone)-based charge transport materials | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-06-20 | — | — | EP | disclosed |
| US-20060177750-A1 | Charge transport materials having a nitrogen-containing-heterocycle hydrazone group | S-PRINTING SOLUTION CO., LTD. (KR) | 2006-08-10 | — | — | US | disclosed |
| EP-1584987-A2 | Poly(hydrazone)-based charge transport materials | Samsung Electronics Co., Ltd. (KR) | 2005-10-12 | — | — | EP | disclosed |
| US-20050221212-A1 | Poly(hydrazone)-based charge transport materials | S-PRINTING SOLUTION CO., LTD. (KR) | 2005-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060177750-A1 | Charge transport materials having a nitrogen-containing-heterocycle hydrazone group | SLC1A2, SLC9B2, SLC6A19 | DHFR 2490/4885PTGER4 1086/4885MAPT 4102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.